Free Stock Tips

Hi Everybody,

We have a stock with a great story and big upside potential so let’s get right to it.

We are talking about Plandai Biotechnology, PLPL
The stock closed Thursday at 47.5 cents.

PLPL and its subsidiaries develop highly bioavailable, phytonutrient rich extracts for use in the pharmaceutical, cosmeceutical, wellness, nutraceutical, anti-aging, and food and beverage industries.

PLPL controls every aspect of the process, growing the green tea, avocados, and citrus on its farms in South Africa, to producing the Phytofare™ extracts in-house.

PLPL extracts are being utilized to treat a multitude of diseases and conditions including boosting the immune system, fighting obesity, lowering cholesterol, and aiding in the prevention of cancers, malaria, and many other parasitic and viral infections.

But what might get investors really excited about PLPL is it’s developing and testing of a new Phytofare™ botanical extract derived from cannabis.

The approval was a landmark decision by the FDA and shows that the FDA is ready to embrace cannabis as a treatment.

PLPL believes the timing is perfect and has entered the medical marijuana arena through its new wholly-owned subsidiary Cannabis Biosciences Inc.

PLPL’s proposed extract would be a compound of all active phyto-cannabinoids, less THC, so it’s potential as an anti-cancer agent is compelling!

PLPL has stated its goal is to have most of the trials it has commissioned completed by the end of March 2014.

Investors love clinical trials. This week alone OCLS, PBYI, OMED, and ABIO were up BIG on FDA and clinical trial news.

PLPL’s revenue growth has been impressive, from zero revenue in fiscal 2012, to some revenue in fiscal 2013, last week PLPL reported revenues for the quarter ending Sept. 30 2013 which is their first quarter of fiscal 2014, and those revenues alone nearly matched the total revenue for 2013! Not to mention it was the first quarter the company recorded a gross profit.

With the news of growing revenues circulating, as well as the prospects of clinical trial news on the horizon, PLPL looks ready for its next big move.

Make sure PLPL is on top of your watchlist Friday morning.

As always, do your own research, don’t chase gaps, use limit orders to enter positions, always use stop loss orders to protect your position, and take profits when you are in a position to do so.

Good Trading